Empowered Funds
KYTX icon

Empowered Funds’s Kyverna Therapeutics KYTX Stock Holding History

Empowered Funds’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$127K Buy
+18,683
New +$147K ﹤0.01% 2379

Other funds holding KYTX

Gilead Sciences
Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Empowered Funds's KYTX Position: Q3 2026 in Review

Empowered Funds opened a new position in Kyverna Therapeutics (KYTX) in Q3 2026: 18,683 shares worth $127K. The stake represents ﹤0.01% of the portfolio and ranks #2379 among its holdings.

82 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.

  • Empowered Funds held 18,683 shares of Kyverna Therapeutics worth $127K as of Q3 2026.
  • Kyverna Therapeutics was a new Empowered Funds position in Q3 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2379 holding.
  • 82 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.